Efficacy and safety of chimeric antigen receptor (CAR)-T cell therapy in the treatment of relapsed and refractory multiple myeloma: a systematic-review and meta-analysis of clinical trials

BACKGROUND: Multiple myeloma (MM) is a malignant tumor originating from plasma cells in the bone marrow. The existing treatment methods can prolong the survival time of patients, but they still face the problems of myeloma relapse and refractory disease. Chimeric antigen receptor (CAR)-T cell therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingjing, Tang, Yuanyan, Huang, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990219/
https://www.ncbi.nlm.nih.gov/pubmed/35402175
http://dx.doi.org/10.21037/tcr-22-344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990219/
https://www.ncbi.nlm.nih.gov/pubmed/35402175
http://dx.doi.org/10.21037/tcr-22-344

Ejemplares similares